Labcorp Holdings, Inc. (LH)
339.64
+3.30
(+0.98%)
USD |
NYSE |
Aug 24, 16:00
339.64
0.00 (0.00%)
After-Hours: 20:00
Labcorp Holdings Enterprise Value : 33.85B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 33.85B |
| August 20, 2026 | 33.57B |
| August 19, 2026 | 33.37B |
| August 18, 2026 | 32.71B |
| August 17, 2026 | 32.80B |
| August 14, 2026 | 32.38B |
| August 13, 2026 | 32.74B |
| August 12, 2026 | 32.81B |
| August 11, 2026 | 32.72B |
| August 10, 2026 | 32.63B |
| August 07, 2026 | 32.46B |
| August 06, 2026 | 32.25B |
| August 05, 2026 | 32.04B |
| August 04, 2026 | 31.91B |
| August 03, 2026 | 31.51B |
| July 31, 2026 | 31.65B |
| July 30, 2026 | 32.17B |
| July 29, 2026 | 31.49B |
| July 28, 2026 | 32.06B |
| July 27, 2026 | 31.01B |
| July 24, 2026 | 30.65B |
| July 23, 2026 | 30.18B |
| July 22, 2026 | 29.41B |
| July 21, 2026 | 29.24B |
| July 20, 2026 | 29.41B |
| Date | Value |
|---|---|
| July 17, 2026 | 29.56B |
| July 16, 2026 | 29.45B |
| July 15, 2026 | 28.64B |
| July 14, 2026 | 28.94B |
| July 13, 2026 | 29.02B |
| July 10, 2026 | 29.03B |
| July 09, 2026 | 29.10B |
| July 08, 2026 | 29.11B |
| July 07, 2026 | 29.60B |
| July 06, 2026 | 29.65B |
| July 02, 2026 | 29.86B |
| July 01, 2026 | 29.61B |
| June 30, 2026 | 29.29B |
| June 29, 2026 | 29.29B |
| June 26, 2026 | 28.62B |
| June 25, 2026 | 28.20B |
| June 24, 2026 | 28.10B |
| June 23, 2026 | 27.56B |
| June 22, 2026 | 27.22B |
| June 18, 2026 | 27.33B |
| June 17, 2026 | 27.64B |
| June 16, 2026 | 28.07B |
| June 15, 2026 | 28.09B |
| June 12, 2026 | 28.18B |
| June 11, 2026 | 28.11B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 33.02B |
| DaVita, Inc. | 24.68B |
| CVS Health Corp. | 181.42B |
| OPKO Health, Inc. | 1.201B |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 299.10M |
| Revenue (Quarterly) | 3.731B |
| Total Expenses (Quarterly) | 3.432B |
| EPS Diluted (Quarterly) | 3.643 |
| Gross Profit Margin (Quarterly) | 27.71% |
| Profit Margin (Quarterly) | 8.02% |
| Earnings Yield | 3.56% |
| Operating Earnings Yield | 5.78% |
| Normalized Earnings Yield | 3.889 |